LI
Lipocine Inc
🇺🇸XNAS.LPCNUnited StatesHealthcare
$2.16USDup +0.01 (+0.47%)ClosedEnd of day11:27 PM
Price$2.16+0.01 (+0.47%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US53630X2036
- CUSIP
- 53630X104
Company
- Employees
- 14
- Headquarters
- Salt Lake City, United States
- Website
- https://www.lipocine.com
- CEO
- Dr. Mahesh V. Patel Ph.D.
Market
- Shares outstanding
- 8.2M
- Market cap
- $17.81M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $17.73M
- EPS LTM
- -$1.44
- P/E LTM
- -1.77
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.57M-62.7%down year on year
- Net income
- -$11.85M-162.94%down year on year
- Gross margin
- -440.81%-1,013.02%down year on year
- Free cash flow
- -$11.19M-120.44%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.